Fleas are the most common ectoparasite in cats and dogs and are capable of spreading and/or causing a number of diseases that affect cats, dogs and even humans, including tapeworm, flea allergy dermatitis (FAD), bartonellosis and endemic typhus. Diseases spread by ticks include anaplasmosis, Lyme borreliosis, babesiosis, tick-borne encephalitis and ehrlichiosis, many of which can cause serious diseases in humans. In dogs, many of these diseases can be lethal and cannot yet be treated, meaning that prevention is key to their management. The most effective disease prevention technique is to stop parasites from biting, removing any possibility of disease transmission.
The ability of a treatment to prevent biting is commonly referred to as 'repellency' (anti-feeding) - products that offer repellency, like Seresto, have been demonstrated in field studies to reduce the risk of disease transmission.
About Bayer HealthCare
The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of EUR 17.2 billion (2011), is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer HealthCare's aim is to discover, develop, manufacture and market products that will improve human and animal health worldwide. Bayer HealthCare has a global workforce of 55,700 employees (Dec 31, 2011) and is represented in more than 100 countries. Find more information at http://www.bayerhealthcare.com.
With a turnover of EUR 1.190 million (2011) Bayer HealthCare's Animal Health Division is one of the world's leading manufacturers of veterinary drugs. The division manufactures and markets more than 100 different veterinary drugs and care products for livestock and companion animals.
Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at http://www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
1. BG, CZ, EE, HU, LT, LV, PL, RO, SK, SI
2. Stanneck D, et al. Parasite & Vectors 2012; In Press
3. WSAVA: World Small Animal Veterinary Association
4. FECAVA: Federation of European Companion Animal Veterinary Association
5. BSAVA: British Small Animal Veterinary Association
CONTACT: Contact: Kathrin Statz, Kathrin.Statz@bayer.com,+49-2173-38-40-19
